Latest Development Pipeline News

Page 2 of 32
Ingenia Communities reports a steady first half of FY26, maintaining full-year guidance at the top of its range, driven by accelerating development settlements and growth across rental and holiday segments.
Eva Park
Eva Park
24 Feb 2026
Neurotech International has reported positive long-term safety results for its lead drug candidate NTI164, bolstering its path towards regulatory approval and chronic use in paediatric neurological disorders.
Ada Torres
Ada Torres
23 Feb 2026
Horizon Gold has reported significant high-grade gold intercepts from recent drilling at its Kingfisher prospect within the Gum Creek Gold Project, revealing new down-plunge extensions and enhancing the project's resource outlook.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.
Ada Torres
Ada Torres
20 Feb 2026
Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.
Ada Torres
Ada Torres
20 Feb 2026
Newmont Corporation’s 2025 Annual Report reveals a robust financial performance driven by higher gold prices and portfolio optimisation, alongside significant progress in key development projects and sustainability initiatives.
Maxwell Dee
Maxwell Dee
20 Feb 2026
Peet Limited has reported a robust half-year performance with statutory profit doubling and a significant dividend increase, underpinned by strong sales and settlements across key Australian markets.
Eva Park
Eva Park
19 Feb 2026
Aspen Group Limited reported a robust half-year result for December 2025, with statutory profit up 15% and a 51% surge in underlying earnings, driven by rental portfolio expansion and accelerated development settlements.
Eva Park
Eva Park
19 Feb 2026
Charter Hall Group has reported a strong first half for FY26, with operating earnings surging 21.6% and record equity inflows driving funds under management to $92.2 billion. The group has upgraded its full-year earnings guidance, signalling confidence amid ongoing market volatility.
Eva Park
Eva Park
19 Feb 2026
Goodman Group reported a slight dip in operating profit for the half year ended 31 December 2025, while statutory profit rose and the total portfolio value expanded to $87.4 billion. The group maintained its interim distribution at 15 cents per security amid ongoing investment in logistics and digital infrastructure.
Eva Park
Eva Park
19 Feb 2026
Vicinity Centres reports a robust FY26 interim profit of $805.6 million, driven by strong leasing and portfolio premiumisation, including the strategic acquisition of Uptown in Brisbane.
Eva Park
Eva Park
18 Feb 2026
Vicinity Centres reported a strong first half of FY26 with a statutory net profit of $805.6 million, strategic acquisitions including full ownership of Uptown Brisbane, and reaffirmed guidance for the full year.
Eva Park
Eva Park
18 Feb 2026